🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Background: * One way tumors are able to grow is by forming new blood vess...
Status
Terminated
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2007-12
Trial ID
NCT01372813
Treatments Being Tested
The purpose of this research study is to determine the safety and tolerabil...
Status
Completed
Location
Dana-Farber Cancer Institute
Start Date
2007-07
Trial ID
NCT00496665
Treatments Being Tested
This is a multi-centre, phase II study to assess the efficacy and safety of...
Status
Completed
Location
Research Site
Start Date
2007-07
Trial ID
NCT00508001
Treatments Being Tested
A Phase I open label study to asses the safety and tolerability of ZD6474 i...
Status
Completed
Location
Research Site
Start Date
2005-08
Trial ID
NCT00507091
Treatments Being Tested
Open-label Study to Evaluate the Safety and Tolerability of Vandetanib 300 ...
Status
Completed
Location
Research Site
Start Date
2012-11
Trial ID
NCT01661179
Treatments Being Tested
To assess the objective response rates (by RECIST) to ZD6474 100, 200 and 3...
Status
Completed
Location
Research Site
Start Date
2004-12
Trial ID
NCT00252746
Treatments Being Tested
This randomized, double-blind phase II trial is to assess the efficacy and ...
Status
Completed
Location
Research Site
Start Date
2008-02
Trial ID
NCT00659438
Treatments Being Tested
The main purpose of this trial is to look to see if adding ZD6474 (100 mg o...
Status
Completed
Location
Multiple Locations
Start Date
2005-07
Trial ID
NCT00506051
Treatments Being Tested
The purpose of this study is to define th Maximum Tolerated Dose (MTD) and ...
Status
Completed
Location
Research Site
Start Date
2006-07
Trial ID
NCT00681798
Treatments Being Tested
The purpose of this open label, two stage, phase II study is to evaluate th...
Status
Completed
Location
Research Site
Start Date
2004-11
Trial ID
NCT00098345
Treatments Being Tested